World News: 12:00 GMT Friday 14th September 2018. [Breathtec Biomedical Inc. via Globe Newswire via SPi World News]
VANCOUVER, British Columbia, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: ) (CNSX: ) (FRANKFURT: BTI) (OTCQB: ) (the “Company”) will be presenting at the 2nd Annual RAI$E on the WEST COAST Small-Cap Investing Conference in Vancouver, BC, September 14-15. We will be in Meeting Area #18, meeting investors & brokers for back-to-back meetings; investors & brokers can register online here:
September 14-15 | Fairmont Hotel Vancouver | Vancouver, BC. RAI$E on the WEST COAST is a two-day conference connecting small-cap companies with funds, finance professionals and investors for a FULL DAY of scheduled meetings on Friday and a NETWORKING DAY of World Class Salmon Fishing on Saturday.
ABOUT BREATHTEC BIOMEDICAL INC. Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of airborne analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of certain pathogens. Our primary avenue of investigation is focused on innovation and advances in the field of specialized mass spectrometry.
Breathtec also recently announced that it will be opening a new drug development division and has signed a Letter of Intent (“LOI”) to acquire 100% of the shares of Nash Pharmaceuticals Inc. (“Nash Pharma”). Nash Pharma is a clinical stage pharmaceutical development company focused on drug repurposing in the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). For more information, visit .
Christopher J. Moreau CEOBreathtec Biomedical Inc.604.398.4175 ext 701
Globe Newswire: 12:00 GMT Friday 14th September 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.